This independent lab test from Janoshik confirms Tirzepatide 110.54 mg from HPR at 99.800% purity. The analysis was conducted on December 3, 2025.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its potential role in metabolic regulation, weight management, and glycemic control. A purity level of 99.800% indicates pharmaceutical-grade synthesis with minimal impurities.
The full certificate of analysis is available for verification at www.janoshik.com/verify/ using key F6Q1NRQXRUZ7.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.